What are the core quality metrics that should be tracked for every stroke patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Stroke Quality Metrics

Every stroke program should track a core set of performance metrics covering acute management, secondary prevention, and outcomes, with the 2023 World Stroke Organization guidelines providing the most comprehensive framework for implementation across all care settings. 1

Core Compulsory Metrics

The European Stroke Organisation identifies 6 mandatory quality indicators that every stroke unit must track 2:

  1. Door-to-needle time <60 minutes for IV thrombolysis patients
  2. Stroke unit admission rate - percentage of all acute stroke patients admitted to stroke unit (or ICU when appropriate)
  3. Brain imaging completion - 100% of suspected stroke patients receiving CT or MRI
  4. Antiplatelet therapy at discharge for ischemic stroke patients
  5. Anticoagulation at discharge for patients with atrial fibrillation
  6. Dysphagia screening - percentage of patients screened for swallowing disorders

Clinical Significance of Time Metrics

For every 15-minute reduction in door-to-needle time, there is a 5% lower odds of in-hospital mortality (adjusted OR 0.95% CI 0.92-0.98) 3. Despite this, only 26.6% of patients achieve the recommended ≤60 minute door-to-needle time, highlighting a critical quality gap.

Acute Management Metrics

The 2023 World Stroke Organization guidelines provide an extensive acute care metric framework 1:

Time-Critical Interventions

  • Time from stroke onset to healthcare professional assessment (minutes/hours)
  • Proportion receiving stroke severity assessment (e.g., NIHSS)
  • CT scan within 25 minutes of hospital arrival
  • Door-to-needle time for IV thrombolysis
  • Proportion receiving IV thrombolysis among eligible patients
  • Mechanical thrombectomy rates (both early and late window >6 hours)
  • Successful recanalization (mTICI 2b/3) after thrombectomy

Early Hospital Care Processes

  • Aspirin within 48 hours for ischemic stroke
  • DVT prophylaxis administration rate
  • Time to first mobilization from stroke onset
  • Hemicraniectomy for eligible patients with large hemispheric infarction
  • Patient/family stroke education delivery
  • Distribution of discharge locations

Hemorrhagic Stroke Specific

  • Time to antihypertensive therapy in ICH with hypertension
  • Blood pressure control achievement in first 24 hours for ICH
  • Anticoagulation reversal time for anticoagulation-related ICH
  • Therapeutic anticoagulation within 24 hours for cerebral venous sinus thrombosis

Secondary Prevention Metrics

Critical secondary prevention indicators that directly impact recurrent stroke risk 1:

Diagnostic Evaluation

  • Stroke etiology workup initiated within 48 hours
  • Complete brain and vascular imaging (extracranial/intracranial)
  • Cardiac monitoring ≥24 hours completion rate

Risk Factor Management

  • Blood pressure assessment and treatment rates
  • BMI documentation at time of event
  • HbA1c ≤7% achievement in diabetic patients
  • LDL-cholesterol <70 mg/dL (1.8 mmol/L) achievement rate
  • Physical activity engagement (low/moderate intensity, 10 min, 4 days/week)
  • Smoking cessation counseling for active smokers
  • Alcohol reduction counseling (>2 drinks/day men, >1 drink/day women)
  • Sodium intake <2000 mg daily

Specific Interventions

  • Oral anticoagulation for atrial fibrillation patients
  • PFO assessment by neurocardiology team for cryptogenic stroke
  • PFO closure in eligible cryptogenic stroke patients (age 18-60)
  • Carotid endarterectomy within 14 days for severe ipsilateral stenosis
  • Dual antiplatelet therapy within 24 hours for minor stroke (NIHSS ≤3-5) or high-risk TIA (ABCD2 ≥4)

Additional Priority Metrics

The ESO recommends selecting at least 3 of these 7 additional indicators 2:

  1. Vascular imaging completion in ischemic stroke/TIA
  2. Brain imaging within 1 hour for patients arriving within 2 hours of onset
  3. IV thrombolytic therapy utilization rate among eligible patients
  4. Carotid revascularization for ≥50% symptomatic stenosis (NASCET criteria)

Implementation Framework

Data Collection Requirements

Every stroke unit must maintain 2:

  • Local stroke register tracking: age, sex, initial stroke severity, thrombolysis status, discharge disposition, mortality
  • Entry into regional/national databank for benchmarking
  • Multidisciplinary team documentation (weekly meetings with logbook confirmation each patient discussed)

Quality Improvement Structure

Healthcare institutions should establish 3:

  • Multidisciplinary quality improvement committee reviewing benchmarks and outcomes (Class I, Level B)
  • Clinical process improvement team
  • Stroke care data repository to identify gaps and disparities
  • Written protocols for acute intervention and secondary prevention

Common Pitfalls to Avoid

  1. Focusing only on process metrics without outcome tracking - The Get With The Guidelines-Stroke program demonstrates that systematic metric collection drives measurable improvements: IV rtPA use increased from 42.9% to 72.84%, and overall defect-free care improved from 44.0% to 84.3% over 5 years 3

  2. Neglecting gender disparities - Data shows women receive less defect-free care (66.3% vs 71.1% for men) and are less likely to be discharged home, requiring targeted interventions 3

  3. Inadequate documentation of exclusions - When patients don't receive standard treatments, documentation of reasons increased by 13% with quality programs, enabling better understanding of care gaps 3

  4. Missing the 72-hour follow-up window - Patients with disabilities should be followed within 72 hours by specialist stroke rehabilitation teams 1

Outcome Metrics for Comprehensive Assessment

Beyond process measures, track 4:

  • Neurological status at 24 hours
  • Ambulatory status at discharge
  • Modified Rankin Scale at 30 and 90 days
  • Hospital mortality rates
  • Discharge disposition patterns

The most recent 2023 World Stroke Organization synthesis provides the definitive framework, recognizing that hospitals should maintain data collection systems and participate in external stroke data repositories to enable continuous quality improvement and benchmarking 1.

Related Questions

Is it normal for a post‑stroke patient to feel cold?
What is the most appropriate first-line antidepressant for a post-stroke patient?
In a 52-year-old male with a history of embolic cerebrovascular accident (stroke) presenting with several months of postprandial fullness, epigastric pain, and unintentional weight loss, and computed tomography (CT) with contrast showing gastric wall thickening and multiple enlarged regional lymph nodes, what diagnostic workup (laboratory tests, imaging, endoscopic procedures), differential diagnoses, and treatment options should be considered?
What is the appropriate workup and management for an 87-year-old man presenting with acute altered mental status and a CT and MRI that are negative for stroke or other acute intracranial pathology?
What are the causes, signs, and symptoms of stroke in young adults (typically under 45 years)?
What is the best medication for an adult with obsessive‑compulsive disorder?
What is the significance and recommended evaluation for a mildly elevated bilirubin of 1.6 mg/dL in a patient with a prior cholecystectomy?
What is the recommended evaluation and management for a 50-year-old perimenopausal woman with elevated sex hormone‑binding globulin (SHBG) and low dehydroepiandrosterone sulfate (DHEA‑S)?
What are the appropriate hormone therapy options, dosing, contraindications, and monitoring for a post‑menopausal woman (with or without uterus) with vasomotor symptoms, a man with advanced prostate cancer, and a transgender woman?
What PRN medication is recommended for agitation in a 60-year-old man with diabetes, Parkinson's disease, cognitive impairment, and coronary artery disease who is currently taking quetiapine 50 mg three times daily?
Is Metaxalone appropriate for a young adult male with chronic low back pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.